Ascentage Pharma Group International (AAPG) Intangibles (2022 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Intangibles for 4 consecutive years, with $9.3 million as the latest value for Q4 2025.
- For Q4 2025, Intangibles fell 12.13% year-over-year to $9.3 million; the TTM value through Dec 2025 reached $9.3 million, down 12.13%, while the annual FY2025 figure was $9.4 million, 9.44% down from the prior year.
- Intangibles hit $9.3 million in Q4 2025 for Ascentage Pharma Group International, down from $10.6 million in the prior quarter.
- Across five years, Intangibles topped out at $10.6 million in Q4 2024 and bottomed at $4.0 million in Q4 2022.
- Average Intangibles over 4 years is $7.6 million, with a median of $8.0 million recorded in 2023.
- Year-over-year, Intangibles soared 65.95% in 2023 and then dropped 12.13% in 2025.
- Ascentage Pharma Group International's Intangibles stood at $4.0 million in 2022, then skyrocketed by 65.95% to $6.7 million in 2023, then soared by 58.41% to $10.6 million in 2024, then fell by 12.13% to $9.3 million in 2025.
- According to Business Quant data, Intangibles over the past three periods came in at $9.3 million, $10.6 million, and $6.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.